Atlas Trials

A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials

Clinical trial NCT05439941 · TERMINATED

Trial details

NCT number
NCT05439941
Sponsor
Evelo Biosciences, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2022-06-06
Primary completion
2023-05-25
Enrollment
287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.